nipocalimab treatment

Nipocalimab shows stronger responses in Sjögren’s disease patients with high autoantibody levels

New Phase 2 analyses presented by Johnson & Johnson suggest that adults with moderate-to-severe Sjögren’s disease and elevated disease-driving autoantibodies…